High-precision cell therapies for transplant
orcabiosystems.com (opens in a new tab)Orca Bio is a commercial-stage biotechnology company redefining stem cell transplantation with next-generation cell therapies aimed at substantially better survival rates and far fewer complications. Traditional allogeneic transplant has been the best hope available for many patients while carrying the risk of being fatal itself or producing serious conditions such as graft-versus-host disease — a treatment where the cure and the danger are the same intervention. Orca's purified, high-precision therapies aim not only to replace a patient's blood and immune system with a healthy one but to restore their life afterwards.